These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2009518)
1. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518 [TBL] [Abstract][Full Text] [Related]
2. Endocytosis and intracellular routing of an antibody-ricin A chain conjugate. Calafat J; Molthoff C; Janssen H; Hilkens J Cancer Res; 1988 Jul; 48(13):3822-7. PubMed ID: 3132322 [TBL] [Abstract][Full Text] [Related]
3. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin. Carrière D; Casellas P; Richer G; Gros P; Jansen FK Exp Cell Res; 1985 Feb; 156(2):327-40. PubMed ID: 2857124 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics. van Oosterhout YV; Preijers FW; Wessels HM; de Witte T Cancer Res; 1992 Nov; 52(21):5921-5. PubMed ID: 1394218 [TBL] [Abstract][Full Text] [Related]
5. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. Griffin T; Raso V Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Byers VS; Pimm MV; Pawluczyk IZ; Lee HM; Scannon PJ; Baldwin RW Cancer Res; 1987 Oct; 47(20):5277-83. PubMed ID: 3498532 [TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
8. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines. Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523 [TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451 [TBL] [Abstract][Full Text] [Related]
13. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. Ramakrishnan S; Bjorn MJ; Houston LL Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383 [TBL] [Abstract][Full Text] [Related]
14. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain. Trown PW; Reardan DT; Carroll SF; Stoudemire JB; Kawahata RT Cancer Res; 1991 Aug; 51(16):4219-25. PubMed ID: 1868442 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin. Griffin TW; Pagnini PG; Houston LL J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277 [TBL] [Abstract][Full Text] [Related]
16. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas. Kornfeld SB; Leonard JE; Mullen MD; Taetle R Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899 [TBL] [Abstract][Full Text] [Related]
18. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells. Magnusson S; Kjeken R; Berg T Exp Cell Res; 1993 Mar; 205(1):118-25. PubMed ID: 8453986 [TBL] [Abstract][Full Text] [Related]
19. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469 [TBL] [Abstract][Full Text] [Related]
20. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins. Manske JM; Buchsbaum DJ; Vallera DA J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]